«Long-acting diltiazem HCl for the chronotherapeutic treatment of hypertension and chronic stable angina pectoris». Expert Opinion on Pharmacotherapy6 (5): 765–76. May 2005. doi:10.1517/14656566.6.5.765. PMID15934903.
Fenakel K, Lurie S. (1990). «The use of calcium channel blockers in obstetrics and gynecology; a review.». Eur J Obstet Gynecol Reprod Biol37 (3): 199–203. doi:10.1016/0028-2243(90)90025-v. PMID2227064.
«The role of existing and newer calcium channel blockers in the treatment of hypertension». Journal of Clinical Hypertension6 (11): 621–29; quiz 630–31. November 2004. doi:10.1111/j.1524-6175.2004.03683.x. PMID15538095.
«General framework for the quantitative prediction of CYP3A4-mediated oral drug interactions based on the AUC increase by coadministration of standard drugs». Clinical Pharmacokinetics46 (8): 681–96. 2007. doi:10.2165/00003088-200746080-00005. PMID17655375.
«Cardiovascular adverse drug reaction associated with combined beta-adrenergic and calcium entry-blocking agents». Journal of Cardiovascular Pharmacology35 (4): 556–59. April 2000. doi:10.1097/00005344-200004000-00007. PMID10774785.
«Effects of atrio-ventricular conduction of calcium-antagonistic coronary vasodilators, local anaesthetics and quinidine injected into the posterior and the anterior septal artery of the atrio-ventricular node preparation of the dog». Naunyn-Schmiedeberg's Archives of Pharmacology294 (2): 169–77. August 1976. doi:10.1007/bf00507850. PMID1012337.
«The pharmacological basis and pathophysiological significance of the heart rate-lowering property of diltiazem». Fundamental & Clinical Pharmacology13 (2): 145–53. 1999. doi:10.1111/j.1472-8206.1999.tb00333.x. PMID10226758.
«Long-acting diltiazem HCl for the chronotherapeutic treatment of hypertension and chronic stable angina pectoris». Expert Opinion on Pharmacotherapy6 (5): 765–76. May 2005. doi:10.1517/14656566.6.5.765. PMID15934903.
Fenakel K, Lurie S. (1990). «The use of calcium channel blockers in obstetrics and gynecology; a review.». Eur J Obstet Gynecol Reprod Biol37 (3): 199–203. doi:10.1016/0028-2243(90)90025-v. PMID2227064.
«The role of existing and newer calcium channel blockers in the treatment of hypertension». Journal of Clinical Hypertension6 (11): 621–29; quiz 630–31. November 2004. doi:10.1111/j.1524-6175.2004.03683.x. PMID15538095.
Om Talreja; Manouchkathe Cassagnol. (2019). «Diltiazem». Treasure Island (FL): StatPearls Publishing. PMID30422532.
«General framework for the quantitative prediction of CYP3A4-mediated oral drug interactions based on the AUC increase by coadministration of standard drugs». Clinical Pharmacokinetics46 (8): 681–96. 2007. doi:10.2165/00003088-200746080-00005. PMID17655375.
«Cardiovascular adverse drug reaction associated with combined beta-adrenergic and calcium entry-blocking agents». Journal of Cardiovascular Pharmacology35 (4): 556–59. April 2000. doi:10.1097/00005344-200004000-00007. PMID10774785.
«Effects of atrio-ventricular conduction of calcium-antagonistic coronary vasodilators, local anaesthetics and quinidine injected into the posterior and the anterior septal artery of the atrio-ventricular node preparation of the dog». Naunyn-Schmiedeberg's Archives of Pharmacology294 (2): 169–77. August 1976. doi:10.1007/bf00507850. PMID1012337.
«The pharmacological basis and pathophysiological significance of the heart rate-lowering property of diltiazem». Fundamental & Clinical Pharmacology13 (2): 145–53. 1999. doi:10.1111/j.1472-8206.1999.tb00333.x. PMID10226758.